Novartis Q4 Profit Down, Core EPS Beat Market; Lifts Dividend; Sees Growth In FY25
Swiss drug major Novartis AG (NVS) reported Friday that its fourth-quarter net income plunged to $2.82 billion from last year's $8.48 ...